Legal News

U.S. District Court Judge Mark Kearney recently dismissed the class-action lawsuit of a Pennsylvania pharmacist who claimed CVS failed to pay him overtime pay.

Today’s pharmacist is much more than a healthcare professional who oversees the distribution of drugs. Pharmacists can be and often are the patient’s first-line healthcare educator and risk manager.

That’s the allegation made in a potential class action lawsuit that claims CVS deliberately overcharged some customers for generic drugs by submitting claims to their insurance companies at inflated prices.

The U.S. Court of Appeals for the Federal Circuit in Washington has ruled that Novartis AG’s Sandoz may begin selling the first copy of Amgen Inc.’s Neupogen as soon as Sept. 2.

Federal and state laws impose limits on the amount of pseudoephedrine a person may buy and a pharmacy may sell. Your state's limits may be more strict than the limits imposed by the feds.

Pharmacists swear to promote the good of every patient. But stuff can happen. It wouldn't hurt to take out some insurance. Just in case.

The Virginia State Board of pharmacy has temporarily closed a Richmond pharmacy from which more than 50,000 controlled substances were stolen during a two-year period, including oxycodone, hydrocodone, and methadone.

Some tips on what constitutes a QA and how to comply with pharmacy law when creating one.

Although the biosimilar Zarxio (filgrastim-sndz,) was approved in March, the manufacturer, Sandoz/Novartis, has been delayed from selling the drug until a patent dispute with Amgen is resolved.

The probable is not pharmacist glut. The problem is underused pharmacists.

A Mississippi pharmacist has agreed to forfeit $2 million he earned through an online scheme that distributed painkillers to customers who had not received medical consultations.

If you're waffling on the idea of taking out professional liability insurance, read this and think again.

A month after New York ordered Target, Walmart, Walgreens, and GNC to stop selling herbal supplements that routinely did not contain the ingredients advertised, one of the giant retailers has been hit with a class action lawsuit.

A California pharmacist has filed a class-action lawsuit against Walmart, accusing the retail giant of cheating pharmacists out of work breaks and overtime pay.

With only 15% of New York's healthcare providers ready for e-Rx of controlled substances, New York legislators have agreed to push back the March 27 deadline by one year.

A group of 55 pharmacies located mainly in Pennsylvania has turned to the courts to resolve reimbursement differences with Catamaran.

If the draft of the legislation was aimed at misleading the voters, as one of the drafters appears to have admitted, such conduct could constitute gross negligence.

Paper is about to become history in one of the largest prescription drug markets in the country.

A pharmacist's failure to counsel can result in severe, life-changing consequences for the patient.

Among four New York retail chains, only 21% of store-brand supplements tested contained the plant material named on their labels.

FDA is seeking to learn how these Wallcur products, which are not sterile and should not be injected in humans or animals, entered the supply chain.

Agency will use guidance in 2015 to address “key policy issues.”

Agency kicks medical product safety-monitoring into a higher gear.

A judge has reinstated the pharmacy license of a former Rhode Island state senator who mistakenly gave morphine to an infant and a toddler.

Until now, DEA has interpreted the Controlled Substances Act in its own special way. Now two senators launch legislation geared to the needs of everyone else.

In 36 states, a pharmacist's apology will not be construed as an admission of liability. In the other states, it's a different story.

The documents seek to clarify the regulatory process for compounders of sterile human drugs.

Pharmacies that accept copayment coupons should take immediate steps to address the issues raised by OIG.